贝莱德推港元及美元计价恒生科技ETF 初步每手1,500元
贝莱德旗下iShares安硕恒生科技ETF将於周四(17日)上板,设有港元及美元定价,交易编号分别为03067.HK及09067.HK,发行价15元,每手100单位,每手最初定价约为1,500元。
贝莱德亚洲主管陈蕙兰表示,相信未来将会有更多科技股份上市,而中美紧张关系亦未必会影响中国科技公司,由於其大部份收入来自中国,以腾讯(00700.HK)为例,仅得2%收入来自美国市场,相信中国科技股份仍然会受投资者青睐。她又指,投资於指数ETF较个股更能分散风险。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.